The latest price target for Synaptogenix (NASDAQ:SNPX) was reported by Maxim Group on July 11, 2024. The analyst firm set a price target for $14.00 expecting SNPX to rise to within 12 months (a possible 233.33% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for Synaptogenix (NASDAQ:SNPX) was provided by Maxim Group, and Synaptogenix upgraded their buy rating.

The last upgrade for Synaptogenix Inc happened on July 11, 2024 when Maxim Group raised their price target to $14. Maxim Group previously had a hold for Synaptogenix Inc.

The last downgrade for Synaptogenix Inc happened on December 19, 2022 when Maxim Group changed their price target from N/A to N/A for Synaptogenix Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Synaptogenix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Synaptogenix was filed on July 11, 2024 so you should expect the next rating to be made available sometime around July 11, 2025.

While ratings are subjective and will change, the latest Synaptogenix (SNPX) rating was a upgraded with a price target of $0.00 to $14.00. The current price Synaptogenix (SNPX) is trading at is $4.20, which is within the analyst’s predicted range.